Frontlight ResearchEarly access
Trial site
North York Diagnostic and Cardiac Centre
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Obesity8 trials
- Type 2 diabetes8 trials
- Heart failure5 trials
- Coronary artery disease3 trials
- Peripheral artery disease3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Type 1 diabetes1 trial
- Phase
- Phase 311 trials
- Phase 23 trials
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Amgen4 trials
- Canadian Medical and Surgical Knowledge Translation Research Group3 trials
- Bayer1 trial
- Beijing Inno Medicine Co., Ltd.1 trial
- and 2 more
Running trials
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Coronary artery disease1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
Vascular Regenerative Cell Exhaustion in Adults With Peripheral Artery Disease (PAD-VRCE)
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026